Home
VRTX
VRTX News

Latest Vertex Pharmaceuticals Incorporated (VRTX) News on May 27, 2025

Spotting Winners: Myriad Genetics (NASDAQ:MYGN) And Therapeutics Stocks In Q1

StockStory

14 hours ago

Spotting Winners: Myriad Genetics (NASDAQ:MYGN) And Therapeutics Stocks In Q1

3 Top Growth Stocks to Buy in the Second Half of 2025

Motley Fool

a day ago

3 Top Growth Stocks to Buy in the Second Half of 2025

2 Monster Growth Stocks to Buy and Hold for 10 Years

Motley Fool

3 days ago

2 Monster Growth Stocks to Buy and Hold for 10 Years

MT Newswires

4 days ago

Argus Adjusts Price Target on Vertex Pharmaceuticals to $525 From $550

Argus Research

4 days ago

Analyst Report: Vertex Pharmaceuticals, Inc.

Argus Research

4 days ago

Market Digest: AIG, HST, PSA, VRTX

Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030

Motley Fool

6 days ago

Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030

CRISPR Therapeutics Stock Could Double Your Money, According to Wall Street. Is It Time to Buy?

Motley Fool

7 days ago

CRISPR Therapeutics Stock Could Double Your Money, According to Wall Street. Is It Time to Buy?

VRTX Q1 Earnings Call: New Product Launches and Pipeline Progress Amid Revenue Miss

StockStory

8 days ago

VRTX Q1 Earnings Call: New Product Launches and Pipeline Progress Amid Revenue Miss

The Top Corporate Board Directors

The Wall Street Journal

9 days ago

The Top Corporate Board Directors

Warren Buffett Remains Optimistic About America. Here Are Top American Companies Worth Investing In.

Motley Fool

10 days ago

Warren Buffett Remains Optimistic About America. Here Are Top American Companies Worth Investing In.

Exploring High Growth Tech Stocks in the US Market

Simply Wall St.

11 days ago

Exploring High Growth Tech Stocks in the US Market

Are Investors Making a Big Mistake Dumping Shares of CRISPR Therapeutics?

Motley Fool

13 days ago

Are Investors Making a Big Mistake Dumping Shares of CRISPR Therapeutics?

Q1 Therapeutics Earnings: United Therapeutics (NASDAQ:UTHR) Impresses

StockStory

14 days ago

Q1 Therapeutics Earnings: United Therapeutics (NASDAQ:UTHR) Impresses

2 Biotech Stocks That Are Screaming Buys in May

Motley Fool

14 days ago

2 Biotech Stocks That Are Screaming Buys in May

This Stock Just Dropped by 12% in 1 Day. History Says This Will Happen Next

Motley Fool

14 days ago

This Stock Just Dropped by 12% in 1 Day. History Says This Will Happen Next

Prediction: These 2 Stocks Will Outperform the Market in the Next Five Years

Motley Fool

15 days ago

Prediction: These 2 Stocks Will Outperform the Market in the Next Five Years

Can Buying CRISPR Therapeutics and Holding It Forever Make You a Millionaire?

Motley Fool

15 days ago

Can Buying CRISPR Therapeutics and Holding It Forever Make You a Millionaire?

Is Vertex Pharmaceuticals (VRTX) Among the Best Stocks to Buy According to Jim Simons’ Renaissance Technologies?

Insider Monkey

16 days ago

Is Vertex Pharmaceuticals (VRTX) Among the Best Stocks to Buy According to Jim Simons’ Renaissance Technologies?

My Favorite Tariff Safe-Haven Stock to Buy on the Dip

Motley Fool

17 days ago

My Favorite Tariff Safe-Haven Stock to Buy on the Dip

Vertex Pharmaceuticals Incorporated (VRTX) Surged On a Recovery in Investor Sentiment

Insider Monkey

18 days ago

Vertex Pharmaceuticals Incorporated (VRTX) Surged On a Recovery in Investor Sentiment

Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know

Zacks

18 days ago

Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know

Vertex Pharmaceuticals Incorporated Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Simply Wall St.

18 days ago

Vertex Pharmaceuticals Incorporated Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

4 No-Brainer Stocks to Buy Right Now

Motley Fool

18 days ago

4 No-Brainer Stocks to Buy Right Now

Unpacking Q1 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) In The Context Of Other Therapeutics Stocks

StockStory

19 days ago

Unpacking Q1 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) In The Context Of Other Therapeutics Stocks

Viatris’ new form of old pain drug scores in large trials

BioPharma Dive

19 days ago

Viatris’ new form of old pain drug scores in large trials

VRTX Stock Down as Q1 Sales of New Drugs Miss Expectations

Zacks

20 days ago

VRTX Stock Down as Q1 Sales of New Drugs Miss Expectations

MT Newswires

20 days ago

Wolfe Research Downgrades Vertex Pharmaceuticals to Peer Perform From Outperform

Why Vertex Pharmaceuticals Stock Is a Screaming Buy on the Dip

Motley Fool

20 days ago

Why Vertex Pharmaceuticals Stock Is a Screaming Buy on the Dip

1 S&P 500 Stock with Impressive Fundamentals and 2 to Ignore

StockStory

21 days ago

1 S&P 500 Stock with Impressive Fundamentals and 2 to Ignore

Morningstar Research

21 days ago

Analyst Report: Vertex Pharmaceuticals Incorporated

Stocks to Watch Recap: Palantir, Ford, Mattel, DoorDash

The Wall Street Journal

21 days ago

Stocks to Watch Recap: Palantir, Ford, Mattel, DoorDash

S&P 500 Gains & Losses Today: Stocks Fall for Second Day as Palantir, Pharmaceuticals Drop

Investopedia

21 days ago

S&P 500 Gains & Losses Today: Stocks Fall for Second Day as Palantir, Pharmaceuticals Drop

Vertex Pharmaceuticals Topples 10% On A Series Of First-Quarter Setbacks

Investor's Business Daily

21 days ago

Vertex Pharmaceuticals Topples 10% On A Series Of First-Quarter Setbacks

Rising Costs Weigh on Vertex Q1 Earnings

Motley Fool

21 days ago

Rising Costs Weigh on Vertex Q1 Earnings

MT Newswires

21 days ago

Barclays Adjusts Vertex Pharmaceuticals Price Target to $499 From $467, Maintains Equal Weight Rating

MT Newswires

21 days ago

RBC Raises Price Target on Vertex Pharmaceuticals to $423 From $420, Keeps Sector Perform Rating

MT Newswires

21 days ago

Morgan Stanley Lifts Price Target on Vertex Pharmaceuticals to $464 From $462, Keeps Equalweight Rating

Thomson Reuters StreetEvents

21 days ago

Q1 2025 Vertex Pharmaceuticals Inc Earnings Call

MT Newswires

21 days ago

Jefferies Adjusts Price Target on Vertex Pharmaceuticals to $575 From $550, Maintains Buy Rating

MT Newswires

21 days ago

Morgan Stanley Adjusts Price Target on Vertex Pharmaceuticals to $464 From $462, Maintains Equalweight Rating

MT Newswires

21 days ago

JPMorgan Adjusts Price Target on Vertex Pharmaceuticals to $515 From $512, Maintains Overweight Rating

Stock Market Selloff: 4 No-Brainer Stocks to Buy Right Now

Motley Fool

22 days ago

Stock Market Selloff: 4 No-Brainer Stocks to Buy Right Now

3 No-Brainer Stocks to Buy in May

Motley Fool

22 days ago

3 No-Brainer Stocks to Buy in May

5 Growth Stocks to Buy in May and Go Away

Motley Fool

23 days ago

5 Growth Stocks to Buy in May and Go Away

Earnings To Watch: Vertex Pharmaceuticals (VRTX) Reports Q1 Results Tomorrow

StockStory

23 days ago

Earnings To Watch: Vertex Pharmaceuticals (VRTX) Reports Q1 Results Tomorrow

Vertex Pharmaceuticals (VRTX) Outperforms Broader Market: What You Need to Know

Zacks

a month ago

Vertex Pharmaceuticals (VRTX) Outperforms Broader Market: What You Need to Know

What Analyst Projections for Key Metrics Reveal About Vertex (VRTX) Q1 Earnings

Zacks

a month ago

What Analyst Projections for Key Metrics Reveal About Vertex (VRTX) Q1 Earnings

Analysts Estimate Entrada Therapeutics, Inc. (TRDA) to Report a Decline in Earnings: What to Look Out for

Zacks

a month ago

Analysts Estimate Entrada Therapeutics, Inc. (TRDA) to Report a Decline in Earnings: What to Look Out for

Vertex Gears Up to Report Q1 Earnings: Is a Beat in the Cards?

Zacks

a month ago

Vertex Gears Up to Report Q1 Earnings: Is a Beat in the Cards?

Vertex Pharmaceuticals (VRTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Zacks

a month ago

Vertex Pharmaceuticals (VRTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

My 5 Top Stocks to Buy Right Now in This Highly Volatile Market

Motley Fool

a month ago

My 5 Top Stocks to Buy Right Now in This Highly Volatile Market

Wall Street’s New Tariff Safe Haven: High-Tax Biotech Stocks

The Wall Street Journal

a month ago

Wall Street’s New Tariff Safe Haven: High-Tax Biotech Stocks

CRISPR Therapeutics to Report Q1 Earnings: What's in the Cards?

Zacks

a month ago

CRISPR Therapeutics to Report Q1 Earnings: What's in the Cards?

Vertex Pharmaceuticals (VRTX) Advances But Underperforms Market: Key Facts

Zacks

a month ago

Vertex Pharmaceuticals (VRTX) Advances But Underperforms Market: Key Facts

Top 20 biopharmas’ market cap rises 6% in Q1 2025 amid tariff headwinds

Pharmaceutical Technology

a month ago

Top 20 biopharmas’ market cap rises 6% in Q1 2025 amid tariff headwinds

Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It

Zacks

a month ago

Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It

Why Vertex Pharmaceuticals Was Such a Healthy Stock on Tuesday

Motley Fool

a month ago

Why Vertex Pharmaceuticals Was Such a Healthy Stock on Tuesday

3 Relatively Safe Healthcare Growth Stocks You Can Buy and Hold

Motley Fool

a month ago

3 Relatively Safe Healthcare Growth Stocks You Can Buy and Hold

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Zacks

a month ago

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Fed Chairman Jerome Powell Warns Trump's Tariffs Could Cause Stagflation: 3 Stocks to Buy and Hold if He's Right

Motley Fool

a month ago

Fed Chairman Jerome Powell Warns Trump's Tariffs Could Cause Stagflation: 3 Stocks to Buy and Hold if He's Right

Vertex Pharmaceuticals (NasdaqGS:VRTX) Faces UK Patent Lawsuit Over Groundbreaking CASGEVY Therapy

Simply Wall St.

a month ago

Vertex Pharmaceuticals (NasdaqGS:VRTX) Faces UK Patent Lawsuit Over Groundbreaking CASGEVY Therapy

Don't Try to Time the Market: These 2 Stocks Are Buys Regardless of What Happens Next

Motley Fool

a month ago

Don't Try to Time the Market: These 2 Stocks Are Buys Regardless of What Happens Next

MT Newswires

a month ago

BMO Capital Adjusts Price Target on Vertex Pharmaceuticals to $557 From $545

MT Newswires

a month ago

Goldman Sachs Adjusts Price Target on Vertex Pharmaceuticals to $617 From $615, Maintains Buy Rating

Stock Market Whiplash: 3 Growth Stocks That Are No-Brainer Buys on the Bounce

Motley Fool

a month ago

Stock Market Whiplash: 3 Growth Stocks That Are No-Brainer Buys on the Bounce

April 2025's Stocks That May Be Priced Below Their Estimated Value

Simply Wall St.

a month ago

April 2025's Stocks That May Be Priced Below Their Estimated Value

Exploring 3 High Growth Tech Stocks In The US Market

Simply Wall St.

a month ago

Exploring 3 High Growth Tech Stocks In The US Market

Nasdaq Market Whiplash: 3 Stocks to Buy Hand Over Fist and Hold for Decades

Motley Fool

a month ago

Nasdaq Market Whiplash: 3 Stocks to Buy Hand Over Fist and Hold for Decades

Vertex Researcher, Paul Negulescu Ph.D., Receives the 2025 Canada Gairdner International Award for Pioneering Research and Discovery of Medicines for Cystic Fibrosis

Business Wire

2 months ago

Vertex Researcher, Paul Negulescu Ph.D., Receives the 2025 Canada Gairdner International Award for Pioneering Research and Discovery of Medicines for Cystic Fibrosis

Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?

Motley Fool

2 months ago

Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?

Vertex Pharmaceuticals (VRTX) Stock Moves -1.41%: What You Should Know

Zacks

2 months ago

Vertex Pharmaceuticals (VRTX) Stock Moves -1.41%: What You Should Know

Vertex Pharmaceuticals (VRTX) Surged on Increased Demand for its Cystic Fibrosis (CF) Franchise

Insider Monkey

2 months ago

Vertex Pharmaceuticals (VRTX) Surged on Increased Demand for its Cystic Fibrosis (CF) Franchise

We're About to Find Out the Answer to Warren Buffett's Pointed Question About Trump's Tariffs. Here Are 3 Stocks to Buy Depending on What That Answer Is.

Motley Fool

2 months ago

We're About to Find Out the Answer to Warren Buffett's Pointed Question About Trump's Tariffs. Here Are 3 Stocks to Buy Depending on What That Answer Is.

5 Top Growth Stocks to Buy in the Stock Market Sell-Off

Motley Fool

2 months ago

5 Top Growth Stocks to Buy in the Stock Market Sell-Off

MT Newswires

2 months ago

Morgan Stanley Adjusts PT on Vertex Pharmaceuticals to $462 From $459, Keeps Equalweight Rating

Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know

Zacks

2 months ago

Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know

An Intrinsic Calculation For Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Suggests It's 41% Undervalued

Simply Wall St.

2 months ago

An Intrinsic Calculation For Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Suggests It's 41% Undervalued

Jim Cramer Calls Vertex Pharmaceuticals Incorporated (VRTX) “Terrific” With “Revolutionary Pain Drug”

Insider Monkey

2 months ago

Jim Cramer Calls Vertex Pharmaceuticals Incorporated (VRTX) “Terrific” With “Revolutionary Pain Drug”

Is Vertex Pharmaceuticals Incorporated (VRTX) the Best Long Term Growth Stock to Buy According to Billionaires?

Insider Monkey

2 months ago

Is Vertex Pharmaceuticals Incorporated (VRTX) the Best Long Term Growth Stock to Buy According to Billionaires?

2 Stocks to Buy if You're Worried About a Recession

Motley Fool

2 months ago

2 Stocks to Buy if You're Worried About a Recession

Spotting Winners: United Therapeutics (NASDAQ:UTHR) And Therapeutics Stocks In Q4

StockStory

2 months ago

Spotting Winners: United Therapeutics (NASDAQ:UTHR) And Therapeutics Stocks In Q4

Worried About Trump's New Tariffs? These 3 U.S. Companies Are Set to Weather the Storm

Motley Fool

2 months ago

Worried About Trump's New Tariffs? These 3 U.S. Companies Are Set to Weather the Storm

Corporate CFOs Think a Recession Is Coming. Here Are 3 Stocks to Own If They're Right.

Motley Fool

2 months ago

Corporate CFOs Think a Recession Is Coming. Here Are 3 Stocks to Own If They're Right.

Vertex Pharmaceuticals (VRTX) Increases Despite Market Slip: Here's What You Need to Know

Zacks

2 months ago

Vertex Pharmaceuticals (VRTX) Increases Despite Market Slip: Here's What You Need to Know

Q4 Earnings Outperformers: Amgen (NASDAQ:AMGN) And The Rest Of The Therapeutics Stocks

StockStory

2 months ago

Q4 Earnings Outperformers: Amgen (NASDAQ:AMGN) And The Rest Of The Therapeutics Stocks

Is Vertex Pharmaceuticals Incorporated (VRTX) the Best Gene-Editing Stock to Buy?

Insider Monkey

2 months ago

Is Vertex Pharmaceuticals Incorporated (VRTX) the Best Gene-Editing Stock to Buy?

Biotech stocks slide as Marks resignation seen being negative for sector

TipRanks

2 months ago

Biotech stocks slide as Marks resignation seen being negative for sector

VRTX Provides Mixed Updates for Type 1 Diabetes Pipeline Candidates

Zacks

2 months ago

VRTX Provides Mixed Updates for Type 1 Diabetes Pipeline Candidates

MT Newswires

2 months ago

RBC Adjusts Price Target on Vertex Pharmaceuticals to $420 From $408, Maintains Sector Perform Rating

These biotech names aren't facing 'huge concern' from tariffs

Yahoo Finance Video

2 months ago

These biotech names aren't facing 'huge concern' from tariffs

Intellia Focuses on Pipeline Development Amid Stiff Competition

Zacks

2 months ago

Intellia Focuses on Pipeline Development Amid Stiff Competition

Jim Cramer on Vertex Pharmaceuticals (VRTX): “Revolutionary Pain Drug on the Horizon!”

Insider Monkey

2 months ago

Jim Cramer on Vertex Pharmaceuticals (VRTX): “Revolutionary Pain Drug on the Horizon!”

Vertex halts development of diabetes cell therapy after trial failure

Pharmaceutical Technology

2 months ago

Vertex halts development of diabetes cell therapy after trial failure

MT Newswires

2 months ago

Vertex Pharmaceuticals Ends VX-264 Study in Diabetes After Failing to Meet Efficacy Endpoint

Vertex Pharmaceuticals (NasdaqGS:VRTX) Advances Diabetes Portfolio Despite 2% Decline in Share Price

Simply Wall St.

2 months ago

Vertex Pharmaceuticals (NasdaqGS:VRTX) Advances Diabetes Portfolio Despite 2% Decline in Share Price

Is Vertex Pharmaceuticals (VRTX) The Most Expensive Stock Insiders Are Dumping In March?

Insider Monkey

2 months ago

Is Vertex Pharmaceuticals (VRTX) The Most Expensive Stock Insiders Are Dumping In March?

Vertex Pharmaceuticals (VRTX) Stock Moves -1.96%: What You Should Know

Zacks

2 months ago

Vertex Pharmaceuticals (VRTX) Stock Moves -1.96%: What You Should Know

Vertex Announces Program Updates for Type 1 Diabetes Portfolio

Business Wire

2 months ago

Vertex Announces Program Updates for Type 1 Diabetes Portfolio

Rattled by the Stock Market Sell-Off? These 3 Stocks Outperformed the S&P 500 During the Great Recession

Motley Fool

2 months ago

Rattled by the Stock Market Sell-Off? These 3 Stocks Outperformed the S&P 500 During the Great Recession

Share on Social Networks: